These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 663385)

  • 1. Exerimental evaluation of antianginal drugs.
    Esplugues J; Morcillo E; Badía A; Giraldez A; Bello R
    Rev Esp Fisiol; 1978 Mar; 34(1):15-20. PubMed ID: 663385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
    Meyer K; Klocke RC; Schipke JD; Gams E; Korbmacher B
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):326-31. PubMed ID: 18539040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cocaine and caffeine alone and in combination on cardiovascular performance: an experimental hemodynamic and coronary flow reserve study in a canine model.
    Mehta MC; Jain AC; Billie M
    Int J Cardiol; 2004 Nov; 97(2):225-32. PubMed ID: 15458688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aerobic and hemodynamic mechanisms of the antianginal effect of drugs in patients with angina pectoris].
    Vasil'ev AP; Strel'tsova NN
    Klin Med (Mosk); 2004; 82(7):55-9. PubMed ID: 15449777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antianginal drugs for stable angina pectoris.
    Aronow WS
    Ration Drug Ther; 1982 Jan; 16(1):1-7. PubMed ID: 6799985
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological approaches to the therapy of angina.
    Parratt JR
    Adv Drug Res; 1974; 9():103-34. PubMed ID: 4156950
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacological properties of a new anti-anginal agent: amiodarone].
    Moret PR; Boufas D; Fournet PC
    Schweiz Med Wochenschr; 1969 Jul; 99(30):1090-5. PubMed ID: 5351143
    [No Abstract]   [Full Text] [Related]  

  • 8. [Angina pectoris with normal coronary arteries: clinical, hemodynamic and metabolic study].
    Letac B; Berland J; Cribier A; Cazor JL; Hecketsweiler B
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():211-22. PubMed ID: 6407443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of Hongjingtian (Gadol) injection on cardiac hemodynamics and myocardial oxygen consumption of dogs].
    Zhang ZH; Liu JS; Chu JN; Shang XH; Lin CR; Ma XB; Shi TR; Wang M; Wang YH; Li YR; Liu JH; Wu XY; Zhang XD; Zhang DS; Zhao ZH
    Zhongguo Zhong Yao Za Zhi; 2005 Jul; 30(13):1001-5. PubMed ID: 16161429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitroglycerin and dipyridamole on cardiac metabolism and dynamics in a new experimental model of angina pectoris.
    Szekeres L; Csik V; Udvary E
    J Pharmacol Exp Ther; 1976 Jan; 196(1):15-28. PubMed ID: 812980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy.
    Krumenacker M; Roland E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S93-102. PubMed ID: 1282184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A kinetodardiographic approach to the evaluation of antianginal drugs.
    Slany J; Mösslacher H; Kronik G
    Bibl Cardiol; 1976; (35):191-6. PubMed ID: 825098
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of hypocapnia on hemodynamics and myocardial metabolism in anesthetized dogs].
    Toriumi S; Sakata S; Matsumoto Y; Saito T
    Masui; 1991 Apr; 40(4):544-51. PubMed ID: 1904956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
    Makolkin VI; Vakhliaev VD
    Eksp Klin Farmakol; 1996; 59(4):18-20. PubMed ID: 9026181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamic and coronary effects of intravenous verapamil in coronary insufficiency].
    Zygelman M; Mérillon JP; Guiomard A; Eustigneff T; Zannier D; Gourgon R
    Arch Mal Coeur Vaiss; 1981 Jun; 74(6):685-94. PubMed ID: 6794490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacological basis of antianginal drugs.
    Melville KI
    Pharmacol Physicians; 1970 Mar; 4(3):1-8. PubMed ID: 4985076
    [No Abstract]   [Full Text] [Related]  

  • 17. Systemic and coronary hemodynamic actions of the novel inotropic agent, ibopamine, and the de-esterified metabolite and active form, epinine: relationship to left ventricular performance in the dog.
    Kopia GA; Ohlstein EH; Ruffolo RR
    J Pharmacol Exp Ther; 1988 Aug; 246(2):434-40. PubMed ID: 3404441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dose-dependent effect of amrinone on hemodynamics, myocardial circulation and myocardial energy requirement. An experimental study].
    Veit S; Brückner JB; Vogt K; Wagner R; Hess W
    Z Kardiol; 1985 Feb; 74(2):76-84. PubMed ID: 3993153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A method for evaluating antianginal drugs in experimental animals: assessment of myocardial ischemia by myocardial pH.
    Abiko Y; Ichihara K; Sakai K; Sashida H; Ishibashi T
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):271-8. PubMed ID: 2873274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy with coronary dilators].
    Schaper W
    Arzneimittelforschung; 1977; 27(3a):728-30. PubMed ID: 577451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.